|Bid||421.60 x N/A|
|Ask||421.80 x N/A|
|Day's range||414.21 - 458.00|
|52-week range||414.21 - 521.60|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||0.56|
|Earnings date||17 Jun 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
The Dr Martens share price is falling after the footwear company's first set of results since its IPO. Roland Head takes a closer look. The post UK shares: should I buy Dr Martens and Halfords? appeared first on The Motley Fool UK.
Dr. Martens, the classic British boot brand that listed its shares in January, said it had shown its resilience during the coronavirus crisis, delivering annual revenue growth of 15% despite multiple lockdowns which shuttered stores. "We think there's lots to like about Dr. Martens, apart from the valuation," said analysts at Peel Hunt. Dr Martens sold 12.7 million pairs of "Docs" or "DMs" in the year to March 31, up from 11.1 million in the previous year.
The footwear retailer saw sales up 15%, with strong growth in its online business.